# A Study to Evaluate Impact of Ibrutinib on the Quality of Life (QOL) in Patients With Chronic Lymphocytic Leukemia

> **NCT04016636** · — · COMPLETED · sponsor: **Mela Osorio Maria Jose** · enrollment: 50 (actual)

## Conditions studied

- CLL

## Interventions

- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT04016636
- **Lead sponsor:** Mela Osorio Maria Jose
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-12
- **Primary completion:** 2021-08-30
- **Final completion:** 2022-10-15
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-02-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04016636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04016636, "A Study to Evaluate Impact of Ibrutinib on the Quality of Life (QOL) in Patients With Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04016636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*